The purpose of the legislation, which was passed with a vote of 392-37 in the House, is to repeal the flawed sustainable growth rate formula and provide a long-term solution to physician payment rate issues that have plagued the healthcare industry for 20 years.
However, Paul Spitalnic, chief actuary for CMS, said he believes subsequent legislation will need to be passed to address the issues. The new payment rates contained in H.R. 2 “would be adequate for many years,” Mr. Spitalnic wrote in the report. However, he’s concerned with the funding package’s 2025 expiration date. He also noted the rates would likely be inadequate in years with high inflation.
Mr. Spitalnic wrote that he anticipates the physician payment rates under the legislation would be lower than scheduled under the current SGR formula within the next 33 years.
“Absent a change in the method or level of update by subsequent legislation, we expect access to Medicare-participating physicians to become a significant issue in the long term under H.R. 2,” wrote Mr. Spitalnic.
The U.S. Senate will now consider the legislation, which must be passed by April 15 to prevent a 21 percent cut to physicians’ Medicare payments.
More articles on healthcare finance:
9 recent hospital outlook and rating actions
UnitedHealthcare, Scotland Health ink new deal
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
